Short answer

Designers and engineers should explore in situ crosslinking methods to expand the possibilities of bioink selection and improve the functional outcomes of 3D printed tissue constructs.

Field
Commercial Production
Source
Scientific Reports (2019)
Method
Experimental research and development
Evidence
Strong effect

A novel in situ crosslinking technique allows for the 3D printing of advanced cartilage tissue constructs with improved cell viability and functional tissue development. This commercial production research insight is drawn from a 2019 study published in Scientific Reports. Using Experimental research and development, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Designers and engineers should explore in situ crosslinking methods to expand the possibilities of bioink selection and improve the functional outcomes of 3D printed tissue constructs.

Study
Commercial ProductionHigh ImpactStrong effect

In Situ Crosslinking Enhances 3D Bioprinting of Cartilage Tissue Constructs

A novel in situ crosslinking technique allows for the 3D printing of advanced cartilage tissue constructs with improved cell viability and functional tissue development.

Scientific Reports · 2019

01

Key Findings

  • 01The in situ crosslinking technique enabled the printing of non-viscous, photocrosslinkable bioinks.
  • 02The printing process maintained high cell viability and homogenous distribution of MSCs.
  • 03Printed constructs demonstrated increased compressive moduli, sulfated glycosaminoglycans, and collagen content over 56 days of culture.
  • 04The developed approach is generalizable to a range of photocrosslinkable bioinks.
02

Application

Design takeaway

Designers and engineers should explore in situ crosslinking methods to expand the possibilities of bioink selection and improve the functional outcomes of 3D printed tissue constructs.

How to apply

When designing 3D bioprinting systems for tissue regeneration, consider incorporating in situ crosslinking mechanisms to enhance material versatility and construct functionality.

Project actions

  • 01When designing a 3D printed product, consider how the material properties can be controlled during the printing process.
  • 02Investigate how different curing methods (e.g., light, chemical) can affect the final product's integrity and function.
03

Method & Evidence

AimTo develop and evaluate an in situ crosslinking 3D bioprinting approach for engineering functional cartilage tissue.
MethodExperimental research and development
ProcedureA novel in situ crosslinking technique was developed, where bioink is photocured within a photopermeable capillary before deposition. Printing parameters such as capillary length, flow rate, and light intensity were optimized using a modified hyaluronic acid bioink. Mesenchymal stromal cells (MSCs) were incorporated into the bioink, and the printed constructs were cultured for 56 days to assess cell viability, tissue formation, and mechanical properties.
ContextBiomedical engineering, Tissue engineering, Regenerative medicine

Variables

IV["Printing parameters (capillary length, flow rate, light intensity)","In situ crosslinking technique"]
DV["Bioink printability","Cell viability","Cell distribution","Compressive moduli of constructs","Biochemical content (GAGs, collagen)"]
CV["Type of bioink (modified hyaluronic acid)","Cell type (mesenchymal stromal cells)","Culture conditions (chondrogenic media)","Culture duration (56 days)"]
04

Strengths & Limitations

Strengths

  • +Development of a novel and generalizable bioprinting technique.
  • +Demonstration of functional tissue development in vitro.
  • +Comprehensive characterization of construct properties.

Limitations

The complexity of setting up an in situ crosslinking system might be a barrier for some design projects. The need for specialized equipment and materials could also be a limitation.

Reliability & validity

The study's reliability is supported by the detailed description of the methodology and parameter optimization. Validity is enhanced by the comprehensive characterization of both the printing process and the resulting biological constructs, including functional assessments.

Think critically

How might the principles of in situ crosslinking be applied to non-biomedical 3D printing applications to improve material properties or manufacturing efficiency?

05

Design Principles

"Precise control over material curing and deposition is essential for fabricating functional biological constructs."

This research introduces a method to overcome limitations in bioink printability and bioactivity, paving the way for more complex and functional tissue engineering applications. The ability to precisely control the deposition and crosslinking of biomaterials is crucial for developing viable therapeutic solutions.

06

What This Means for Your Design

This study shows a new way to 3D print living tissues, like cartilage, by curing the 'ink' as it's being printed. This makes it easier to use better materials and helps the cells grow into real tissue.

How to use in your project

  • 1.Reference this study when discussing the limitations of current 3D printing materials and how innovative manufacturing techniques can overcome them.
  • 2.Use it to justify the selection of a specific printing method or material in your design project.
07

Add to My Project

08

Quick Cite

Paragraph starter

The development of in situ crosslinking techniques, as demonstrated by Galarraga et al. (2019) in the context of 3D bioprinting cartilage tissue, highlights the critical role of manufacturing process innovation in overcoming material limitations. This approach allows for the precise control of bioink curing during deposition, leading to enhanced structural integrity and cellular viability in engineered tissues, suggesting that similar process-driven innovations could be applied to improve the performance and functionality of various 3D printed products.

09

Source

Scientific Reports

3D bioprinting via an in situ crosslinking technique towards engineering cartilage tissue

journal · 2019

View source

Questions About This Research

What does the research say about in situ crosslinking enhances 3d bioprinting of cartilage tissue constructs?
Designers and engineers should explore in situ crosslinking methods to expand the possibilities of bioink selection and improve the functional outcomes of 3D printed tissue constructs. Evidence: Scientific Reports (2019).
Why does "In Situ Crosslinking Enhances 3D Bioprinting of Cartilage Tissue Constructs" matter for design?
This research introduces a method to overcome limitations in bioink printability and bioactivity, paving the way for more complex and functional tissue engineering applications. The ability to precisely control the deposition and crosslinking of biomaterials is crucial for developing viable therapeutic solutions.
How can designers apply this research?
Designers and engineers should explore in situ crosslinking methods to expand the possibilities of bioink selection and improve the functional outcomes of 3D printed tissue constructs.
What were the main findings?
The in situ crosslinking technique enabled the printing of non-viscous, photocrosslinkable bioinks.. The printing process maintained high cell viability and homogenous distribution of MSCs.. Printed constructs demonstrated increased compressive moduli, sulfated glycosaminoglycans, and collagen content over 56 days of culture.. The developed approach is generalizable to a range of photocrosslinkable bioinks.
What research method was used?
Experimental research and development.
How strong is the evidence?
Evidence strength is rated Strong effect, based on a 2019 journal from Scientific Reports.
What should I do differently in my next project?
When designing 3D bioprinting systems for tissue regeneration, consider incorporating in situ crosslinking mechanisms to enhance material versatility and construct functionality.
What are the limitations?
The study focused on a specific bioink (NorHA) and cell type (MSCs); further validation with other bioinks and cell types is needed. Long-term in vivo efficacy was not assessed.